Discovery of novel antileishmanial molecules from the plant Pentalinon andreuxii
从植物 Pentalinon andreuxii 中发现新型抗利什曼尼分子
基本信息
- 批准号:8083173
- 负责人:
- 金额:$ 80.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-21 至 2010-09-29
- 项目状态:已结题
- 来源:
- 关键词:AfghanistanAmphotericin BAnimal ModelAnimalsAntiparasitic AgentsApoptoticArmy PersonnelBiological FactorsBiological TestingBiteCanis familiarisChemicalsClinical ResearchCountryCutaneousDataDevelopmentDiseaseDrug resistanceFoundationsFractionationFutureGoalsHexanesImmunocompromised HostImmunologyIn VitroIndividualInfectionIraqLaboratoriesLeftLeishmaniaLeishmaniasisLesionMammalian CellMediatingMethodsMexicoMiltefosineMissionMusNational Institute of Allergy and Infectious DiseaseParasitesPathogenesisPathologyPathway interactionsPatientsPermeabilityPharmaceutical PreparationsPharmacologyPlant ComponentsPlant RootsPlant SourcesPlantsPreclinical TestingQuality ControlRageResistanceSafetySand FliesSecureSoldierSourceSterolsSynthesis ChemistryTestingThe science of MycologyToxic effectTropical DiseaseVisceral LeishmaniasisWorkanalogcomparative efficacycompliance behaviorconventional therapydrug developmentendophytic fungiglobal healthin vivokillingsmacrophagemembrane polarityneglectnovelobligate intracellular parasitepreventresistant strainresponsesafety testingstemvector
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abhay R Satoskar其他文献
Molecular characterization and genetic diversity of cutaneous leishmaniasis from North Eastern Pakistan
- DOI:
10.1016/j.actatropica.2021.105964 - 发表时间:
2021-09-01 - 期刊:
- 影响因子:
- 作者:
Nargis Shaheen;Chaitenya Verma;Thalia Pacheco-Fernandez;Greta Volpedo;Aneeqa Hamid;Ismail Zeb;Syed Aizaz Ali Shah;Shah Fahad;Attiya Iqbal;Asma Ashraf;Amjad Khan;Misbah Gul;Muhammad Ilyas Khan;Huma Fatima;Muhammad Afzal;Abhay R Satoskar;Naveeda Akhter Qureshi - 通讯作者:
Naveeda Akhter Qureshi
Abhay R Satoskar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abhay R Satoskar', 18)}}的其他基金
Development of a live attenuated vaccine for visceral leishmaniasis
内脏利什曼病减毒活疫苗的开发
- 批准号:
9725441 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Development of a live attenuated vaccine for visceral leishmaniasis
内脏利什曼病减毒活疫苗的开发
- 批准号:
10115582 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Treating cutaneous leishmaniasis by radio-frequency induced heat (RFH) therapy
通过射频诱导热 (RFH) 疗法治疗皮肤利什曼病
- 批准号:
8331827 - 财政年份:2012
- 资助金额:
$ 80.4万 - 项目类别:
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF
通过靶向 MIF 化学预防和治疗非黑色素瘤皮肤癌
- 批准号:
8230915 - 财政年份:2012
- 资助金额:
$ 80.4万 - 项目类别:
Chemopreventition and treatment of non-melanoma skin cancer by targeting MIF
通过靶向 MIF 化学预防和治疗非黑色素瘤皮肤癌
- 批准号:
8434824 - 财政年份:2012
- 资助金额:
$ 80.4万 - 项目类别:
Visualization of CXCR3 allelic usage in vivo
CXCR3 等位基因体内使用的可视化
- 批准号:
7957584 - 财政年份:2010
- 资助金额:
$ 80.4万 - 项目类别:
Visualization of CXCR3 allelic usage in vivo
CXCR3 等位基因体内使用的可视化
- 批准号:
8066661 - 财政年份:2010
- 资助金额:
$ 80.4万 - 项目类别:
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extract
使用 Pentalinon andrieuxii 根提取物治疗皮肤利什曼病
- 批准号:
7584697 - 财政年份:2009
- 资助金额:
$ 80.4万 - 项目类别:
Treatment of cutaneous leishmaniasis using Pentalinon andrieuxii root extract
使用 Pentalinon andrieuxii 根提取物治疗皮肤利什曼病
- 批准号:
7762723 - 财政年份:2009
- 资助金额:
$ 80.4万 - 项目类别:
相似海外基金
有機分子触媒を用いたAmphotericin Bの合成研究
有机分子催化剂合成两性霉素B的研究
- 批准号:
24K17671 - 财政年份:2024
- 资助金额:
$ 80.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EnLAmB - Enabling global access to affordable generic liposomal amphotericin B injectable formulations via advanced manufacturing technology
EnLAmB - 通过先进的制造技术,使全球能够获得负担得起的通用脂质体两性霉素 B 注射制剂
- 批准号:
MR/X014010/1 - 财政年份:2023
- 资助金额:
$ 80.4万 - 项目类别:
Research Grant
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Study on naturally-occurring peptides potentiating amphotericin B activity
天然存在的肽增强两性霉素 B 活性的研究
- 批准号:
22K05333 - 财政年份:2022
- 资助金额:
$ 80.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2021
- 资助金额:
$ 80.4万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10024667 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
9909193 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10248529 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
10484014 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
10654834 - 财政年份:2020
- 资助金额:
$ 80.4万 - 项目类别:














{{item.name}}会员




